Legend Biotech (LEGN) Non-cash Items (2020 - 2022)
Legend Biotech (LEGN) posted quarterly Non-cash Items of -$64.4 million for Q1 2022, up 11.87% year-on-year from -$57.6 million in Q1 2021, and up 16.72% on a QoQ basis from -$77.3 million in Q3 2021.
Legend Biotech (LEGN) Non-cash Items (2020 - 2022) Analysis & Trends
Legend Biotech (LEGN) has reported Non-cash Items for 3 consecutive years, with -$64.4 million the latest figure, recorded in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Legend Biotech | 8.69 Bn | 7.79 Bn | 129.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -64.41 Mn |
| Mar 31, 2022 | -64.41 Mn |
| Sep 30, 2021 | -77.34 Mn |
| Sep 30, 2021 | -77.34 Mn |
| Jun 30, 2021 | -81.72 Mn |
| Jun 30, 2021 | -81.72 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Sep 30, 2020 | -62.50 Mn |
| Sep 30, 2020 | -62.50 Mn |